BIM
AMED

Bogle Investment Management’s Amedisys AMED Stock Holding History

Bogle Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-104,313
Closed -$12.2M – 278
2018
Q4 		$12.2M Buy
104,313
+2,986
+3% +$352K 0.95% 27
2018
Q3 		$12.7M Buy
+101,327
New +$11.2M 0.91% 48
2016
Q1 		– Sell
-66,749
Closed -$2.62M – 381
2015
Q4 		$2.62M Sell
66,749
-124,913
-65% -$5M 0.19% 155
2015
Q3 		$7.28M Buy
+191,662
New +$8.08M 0.52% 78
2013
Q4 		– Sell
-284,807
Closed -$4.9M – 299
2013
Q3 		$4.9M Buy
+284,807
New +$4.22M 0.5% 77

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bogle Investment Management's AMED Position: Q1 2019 in Review

Bogle Investment Management sold out of Amedisys (AMED) in Q1 2019, closing a stake of 104,313 shares — an estimated $12.2M sold.

Bogle Investment Management first reported a position in AMED in Q3 2013 and held it in 5 quarters. The position peaked at $12.7M in Q3 2018. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

  • Bogle Investment Management reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
  • Bogle Investment Management sold 104,313 Amedisys shares in Q1 2019, an estimated $12.2M.
  • Bogle Investment Management first reported a position in Amedisys in Q3 2013 and held it in 5 quarters.
  • Bogle Investment Management's Amedisys position peaked at $12.7M in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.